Numerous clinical trials evaluate the therapeutic profile of albendazole, primarily investigating intestinal diseases, soil-transmitted helminth infections, lymphatic filariasis, hookworm, trichuriasis, and ascariasis. These studies encompass Phase 1 through Phase 4 interventional protocols as well as observational designs, with recruitment statuses ranging from active and completed to not yet recruiting. Sponsored by diverse entities—including major pharmaceutical companies and academic institutions—this research reflects a broad clinical evaluation effort.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06565507 | NOT_YET_RECRUITING | Brain Cysticercosis |
Universidad Peruana Cayetano Heredia |
2026-12-01 | PHASE2; PHASE3 |
| NCT07707817 | RECRUITING | Onchocerciasis (River Blindness); Schistosomiasis; Soil Transmitted Helminth (STH) Infections; Lymphatic Filariasis |
Uwemedimo Friday Ekpo |
2026-07-01 | |
| NCT07159373 | NOT_YET_RECRUITING | Lymphatic Filariasis; Scabies; Strongyloidiasis |
Medicines Development for Global Health |
2026-03 | PHASE3 |
| NCT07661316 | NOT_YET_RECRUITING | Trichuriasis; Strongyloidiasis; Ascariasis; Hookworm Infection; Soil-Transmitted Helminthiasis |
Mundo Sano Foundation |
2026-11-01 | PHASE3 |
| NCT04713787 | RECRUITING | Trichuriasis |
Asociacion Benefica Prisma |
2024-09-07 | PHASE2 |
| NCT07258173 | NOT_YET_RECRUITING | Trichuris Infection |
Jennifer Keiser |
2026-11-15 | PHASE2 |
| NCT06613997 | NOT_YET_RECRUITING | Loiasis With Positive Blood Microfilaremia; Loiasis |
Programme National de Lutte contre l'Onchocercose, Republic of the Congo |
2025-01-15 | PHASE3 |
| NCT07074444 | RECRUITING | Clonorchiasis |
First Affiliated Hospital of Guangxi Medical University |
2025-07-22 | PHASE4 |
| NCT05949190 | ACTIVE_NOT_RECRUITING | Malnutrition in Pregnancy; Preterm Birth; Child Development; Postpartum Depression; Antepartum Depression |
Washington University School of Medicine |
2023-08-18 | |
| NCT06070116 | ACTIVE_NOT_RECRUITING | Onchocercal Subcutaneous Nodule; Onchocerciasis; Onchocerciasis, Ocular; Onchocerca Infection; Tropical Disease |
Washington University School of Medicine |
2024-04-05 | PHASE2 |
| NCT03435718 | NOT_YET_RECRUITING | Trichuris Infection |
Oxfendazole Development Group |
2024-07 | PHASE2 |
| NCT06282315 | RECRUITING | Soil-Transmitted Helminths |
Insud Pharma |
2025-09-01 | PHASE3 |
| NCT07045493 | ENROLLING_BY_INVITATION | Soil Transmitted Helminth (STH) Infections |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2025-07-10 | PHASE2 |
| NCT06933862 | NOT_YET_RECRUITING | Malnourished Children |
Indonesia University |
2025-05-15 | |
| NCT06265870 | RECRUITING | Eosinophilia |
Prince of Songkla University |
2024-05-01 | |
| NCT06376396 | NOT_YET_RECRUITING | Neurocysticercosis |
R-Evolution Worldwide S.r.l. Impresa Sociale |
2024-06 | PHASE4 |
| NCT06483880 | UNKNOWN | Pulmonary Hydatid Cyst |
Ain Shams University |
2024-02-01 | |
| NCT06631612 | ACTIVE_NOT_RECRUITING | Iron Deficiency Anemia Treatment |
Ain Shams University |
2024-01-01 | PHASE4 |
| NCT03172975 | COMPLETED | Hookworm Infections |
Baylor College of Medicine |
2018-03-01 | PHASE2 |
| NCT04410406 | COMPLETED | Lymphatic Filariasis |
Washington University School of Medicine |
2020-08-20 | PHASE3 |
| NCT04311671 | COMPLETED | Onchocerciasis |
Medicines Development for Global Health |
2021-05-03 | PHASE3 |
| NCT06184399 | COMPLETED | Trichuriasis; Ascariasis; Hookworm Infections |
Jennifer Keiser |
2024-06-05 | PHASE2 |
| NCT06188715 | COMPLETED | Trichuriasis; Ascariasis; Hookworm Infections |
Jennifer Keiser |
2024-05-14 | PHASE3 |
| NCT03014167 | COMPLETED | Helminthiasis; Filariasis |
University of Washington |
2017-10-04 | PHASE3 |
| NCT04966702 | COMPLETED | Malaria |
Barcelona Institute for Global Health |
2022-03-17 | PHASE3 |
| NCT05208333 | UNKNOWN | Toxocara Infection |
Pham Ngoc Thach University of Medicine |
2022-05 | |
| NCT06037876 | COMPLETED | Trichuriasis |
Jennifer Keiser |
2023-10-09 | PHASE3 |
| NCT06201559 | COMPLETED | Intestinal Diseases |
GlaxoSmithKline |
2023-08-21 | PHASE1 |
| NCT04913610 | TERMINATED | Onchocerciasis |
AbbVie |
2021-05-22 | PHASE2 |
| NCT06201559 | Completed | Intestinal Diseases |
GlaxoSmithKline |
2023-08-21 | Phase 1 |
| NCT05538767 | COMPLETED | Hookworm Infections |
Jennifer Keiser |
2022-09-16 | PHASE2 |
| NCT03950037 | WITHDRAWN | Subarachnoid Neurocysticercosis |
Oregon Health and Science University |
2022-01-01 | PHASE2 |
| NCT05124691 | TERMINATED | Helminthes; Infestation, Intestinal |
Barcelona Institute for Global Health |
2022-01-20 | PHASE2; PHASE3 |
| NCT05354258 | UNKNOWN | Malaria; Soil Transmitted Helminths; Schistosomiasis; Integrated Control; Seasonal Malaria Chemoprevention; Mass Drug Administration With Anthelminthic Drugs |
London School of Hygiene and Tropical Medicine |
2022-06-16 | |
| NCT05453045 | UNKNOWN | Pharmacological Action |
Universidad Nacional de Salta |
2022-07-18 | |
| NCT05453045 | Not yet recruiting | Pharmacological Action |
Universidad Nacional de Salta|Fundacion Mundo Sano |
2022-07-18 | Not Applicable |
| NCT05283954 | WITHDRAWN | SARS-CoV2 Infection; COVID-19 |
Oriol Mitja |
2022-05-01 | PHASE2; PHASE3 |
| NCT02812615 | UNKNOWN | Malnutrition; Infection |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2016-07-16 | |
| NCT04188301 | COMPLETED | Onchocerciasis |
Washington University School of Medicine |
2019-12-06 | PHASE2 |
| NCT03570814 | COMPLETED | Trachoma; Lymphatic Filariases |
London School of Hygiene and Tropical Medicine |
2021-12-01 | PHASE4 |
| NCT04726969 | COMPLETED | Trichuriasis; Ascariasis; Hookworm Infections |
Jennifer Keiser |
2021-06-15 | PHASE3 |
| NCT04700423 | COMPLETED | Trichuriasis; Ascariasis; Hookworm Infections; Helminthes; Infestation, Intestinal |
Jennifer Keiser |
2021-03-01 | PHASE2; PHASE3 |
| NCT04391998 | UNKNOWN | Anemia of Pregnancy |
Cairo University |
2020-05-13 | PHASE4 |
| NCT02876146 | COMPLETED | Alveolar Echinococcosis |
Centre Hospitalier Universitaire de Besancon |
2012-06 | |
| NCT07182305 | COMPLETED | Alveolar Echinococcosis |
Ministry of Health, Kyrgyzstan |
2017-05-01 | PHASE2 |
| NCT02947581 | TERMINATED | Neurocysticercosis |
Universidad Peruana Cayetano Heredia |
2016-11-14 | PHASE3 |
| NCT02636803 | WITHDRAWN | Helminthiasis |
Johns Hopkins Bloomberg School of Public Health |
2019-11 | PHASE2 |
| NCT03527732 | COMPLETED | Trichuriasis |
Jennifer Keiser |
2018-09-09 | PHASE2; PHASE3 |
| NCT04041453 | COMPLETED | Trichuris Infection; Helminthiasis |
Alejandro Krolewiecki |
2019-10-09 | PHASE2 |
| NCT03036059 | COMPLETED | Lymphatic Filariasis; Helminth Infection |
Noguchi Memorial Institute for Medical Research |
2017-05-19 | PHASE4 |
| NCT04041427 | COMPLETED | Helminthiasis |
Universidad Nacional de Salta |
2019-07-17 | |
| NCT03079388 | COMPLETED | Pregnancy; Malnutrition in Pregnancy; Nutrition Disorders; Stunting |
Washington University School of Medicine |
2017-02-27 | |
| NCT03702530 | COMPLETED | Necator Americanus Infection |
Leiden University Medical Center |
2018-12-17 | |
| NCT03527745 | COMPLETED | Trichuriasis; Hookworm Infections |
Jennifer Keiser |
2018-10-23 | PHASE2 |
| NCT03474276 | COMPLETED | Moderate Acute Malnutrition |
Institut Pasteur |
2018-01-31 | PHASE3 |
| NCT03676140 | COMPLETED | Trachoma; Yaws; Lymphatic Filariases; Scabies; Strongyloidiasis |
Lihir Medical Centre |
2018-10-01 | PHASE3 |
| NCT03664063 | COMPLETED | Lymphatic Filariasis; Yaws; Trauma |
Lihir Medical Centre |
2018-09-01 | PHASE2 |
| NCT02974049 | COMPLETED | Lymphatic Filariasis |
University Hospitals Cleveland Medical Center |
2015-01 | |
| NCT03501251 | COMPLETED | Trichuris Trichiura; Infection |
Swiss Tropical & Public Health Institute |
2018-07-03 | PHASE2 |
| NCT02078024 | COMPLETED | Onchocerciasis |
University Hospitals Cleveland Medical Center |
2014-06 | PHASE3 |
| NCT03465488 | COMPLETED | Soil-transmitted Helminth Infections |
University Ghent |
2016-08-15 | |
| NCT01975441 | COMPLETED | Lymphatic Filariasis |
University Hospitals Cleveland Medical Center |
2014-05 | PHASE2 |
| NCT03177993 | COMPLETED | Lymphatic Filariases; Scabies; Impetigo; Soil Transmitted Helminths |
Washington University School of Medicine |
2017-07-13 | |
| NCT03278431 | COMPLETED | Hookworm Infection |
Swiss Tropical & Public Health Institute |
2017-09-27 | PHASE4 |
| NCT03155035 | COMPLETED | Soil Transmitted Helminths |
Dow University of Health Sciences |
2017-03-07 | |
| NCT02397772 | COMPLETED | Helminthiasis; Nematode Infection; Disease Transmission, Infectious |
London School of Hygiene and Tropical Medicine |
2015-03 | PHASE4 |
| NCT02899936 | COMPLETED | Lymphatic Filariasis |
Washington University School of Medicine |
2016-07 | |
| NCT03032042 | WITHDRAWN | Helminth Infection |
University of California, San Francisco |
2017-01 | PHASE4 |
| NCT03192449 | COMPLETED | Soil Transmitted Helminthiasis; Neglected Tropical Diseases |
Universidad Nacional de Salta |
2016-11-21 | PHASE1 |
| NCT02568098 | COMPLETED | Drug Combination; Pharmacokinetics; Healthy |
University of Oxford |
2015-10 | PHASE1 |
| NCT02845713 | COMPLETED | Wuchereria Bancrofti Infection |
University Hospitals Cleveland Medical Center |
2016-04-17 | PHASE1 |
| NCT02351687 | COMPLETED | Malnutrition |
Washington University School of Medicine |
2014-04 | |
| NCT02597556 | WITHDRAWN | Intestinal Helminthiasis; Diarrhea |
Oxford University Clinical Research Unit, Vietnam |
2016-02 | PHASE4 |
| NCT01825031 | COMPLETED | Human Immunodeficiency Virus |
Anna Griffiths, MRC |
2013-06 | PHASE3 |
| NCT01070277 | UNKNOWN | Chronic Diarrhea; Abdominal Pain; Bloating |
Sheba Medical Center |
2012-03 | |
| NCT02509481 | COMPLETED | Malaria; Lymphatic Filariasis |
Colorado State University |
2015-06 | PHASE2; PHASE3 |
| NCT02725255 | COMPLETED | Helminthiasis; Tinea Capitis; Anemia |
Kenya Medical Research Institute |
2015-05 | PHASE2; PHASE3 |
| NCT02243644 | COMPLETED | Neurocysticercosis |
All India Institute of Medical Sciences |
2014-03 | PHASE3 |
| NCT02102321 | UNKNOWN | Hookworm Stool Burden; Anemia; Exercise Tolerance |
Salmon, Margaret, M.D. |
2014-03 | |
| NCT00755560 | UNKNOWN | Toxocariasis |
Hospital de Niños R. Gutierrez de Buenos Aires |
2008-09 | PHASE3 |
| NCT02641210 | COMPLETED | Chronic Periodontitis |
Federal University of Maranhao |
2015-01 | PHASE4 |
| NCT03238131 | COMPLETED | Onchocerciasis |
University Hospitals Cleveland Medical Center |
2012-04 | PHASE3 |
| NCT02253095 | COMPLETED | Environmental Enteropathy |
Washington University School of Medicine |
2014-10 | |
| NCT01748929 | COMPLETED | Intestinal Diseases, Parasitic |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2014-02-24 | PHASE4 |
| NCT01658774 | COMPLETED | Intestinal Helminthiasis; Ascariasis; Hookworm; Malaria |
London School of Hygiene and Tropical Medicine |
2013-01 | |
| NCT02420574 | COMPLETED | Helminthiasis |
University Ghent |
2014-02 | |
| NCT01903057 | WITHDRAWN | Trachoma; Lymphatic Filariasis |
Emory University |
2014-02 | PHASE4 |
| NCT00511004 | COMPLETED | Lymphatic Filariasis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-07 | PHASE2 |
| NCT01395381 | WITHDRAWN | Kwashiorkor; Marasmus |
Washington University School of Medicine |
2013-01 | |
| NCT01722539 | COMPLETED | Healthy |
Universiteit Antwerpen |
2012-11 | PHASE3 |
| NCT00857116 | COMPLETED | Tuberculosis |
Linkoeping University |
2009-03 | |
| NCT01541631 | UNKNOWN | Anemia; Intestinal Helminthiasis; Intestinal Schistosomiasis; Human Immunodeficiency Virus I Infection; Hematologic Diseases; Opportunistic Infections |
Catholic University of Health and Allied Sciences |
2012-05 | |
| NCT00441285 | COMPLETED | Neurocysticercosis; Epilepsy |
Universidad Peruana Cayetano Heredia |
2010-01 | PHASE2; PHASE3 |
| NCT01192802 | COMPLETED | Intestinal Diseases; Helminthiasis |
Albert Schweitzer Hospital |
2010-08 | PHASE4 |
| NCT01755637 | COMPLETED | Helminthiasis |
GlaxoSmithKline |
2012-04 | PHASE1 |
| NCT01308268 | UNKNOWN | Helminthiasis; Strongyloides Stercoralis Infection |
Universidad Nacional de Salta |
2010-12 | |
| NCT01213576 | TERMINATED | Lymphatic Filariasis |
London School of Hygiene and Tropical Medicine |
2009-01 | |
| NCT01440608 | COMPLETED | Enteropathy |
Washington University School of Medicine |
2011-10 | |
| NCT01459146 | UNKNOWN | Malaria; Schistosomiasis; Helminthiasis; Anemia; Change in Sustained Attention |
Navrongo Health Research Centre, Ghana |
2010-12 | PHASE4 |
| NCT02005653 | COMPLETED | Filarial; Infestation |
Indian Council of Medical Research |
2009-02 | PHASE4 |
| NCT00507221 | COMPLETED | HIV Infections; Helminthiasis |
University of Washington |
2008-02 | |
| NCT00375583 | COMPLETED | Lymphatic Filariasis; Wuchereria Bancrofti Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-09-09 | PHASE2 |
| NCT00290823 | COMPLETED | Neurocysticercosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-04 | PHASE3 |
| NCT01327469 | COMPLETED | Infection by Trichuris Trichiura |
University Ghent |
2010-12 | PHASE4 |
| NCT00347113 | COMPLETED | Anaemia; Malaria; Hepatosplenomegaly |
DBL -Institute for Health Research and Development |
2006-07 | |
| NCT01019083 | COMPLETED | Cholera; Typhoid |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2008-02 | PHASE1; PHASE2 |
| NCT01069198 | COMPLETED | Visceral Leishmaniasis |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2009-10 | |
| NCT00817713 | TERMINATED | HIV Infections; Helminthiasis |
Swiss Tropical & Public Health Institute |
2009-01 | |
| NCT00765024 | COMPLETED | Chronic Strongyloidiasis |
Mahidol University |
2008-07 | PHASE3 |
| NCT01586169 | COMPLETED | Parasitic Diseases; Bacterial Diseases |
Centre d'Appui à la lutte contre la Maladie |
2010-02 | |
| NCT01087099 | COMPLETED | Infections With Soil-Transmitted Helminths (STH) |
University Ghent |
2009-01 | PHASE4 |
| NCT01050452 | COMPLETED | Parasitic Diseases |
DBL -Institute for Health Research and Development |
2007-10 | |
| NCT02784743 | COMPLETED | Lymphatic Filariasis |
Centre d'Appui à la lutte contre la Maladie |
2001-05 | PHASE4 |
| NCT01050374 | COMPLETED | Parasitic Diseases |
DBL -Institute for Health Research and Development |
2007-10 | |
| NCT00339417 | COMPLETED | Lymphatic Filariasis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-02-22 | PHASE2 |
| NCT00367627 | COMPLETED | Helminthiasis |
International Centre for Diarrhoeal Disease Research, Bangladesh |
2006-12 | |
| NCT01050517 | COMPLETED | Parasitic Diseases |
DBL -Institute for Health Research and Development |
2007-10 | |
| NCT00659997 | COMPLETED | Ascariasis; Trichuriasis |
Natural History Museum, United Kingdom |
2006-06 | PHASE4 |
| NCT00283699 | COMPLETED | Neurocysticercosis |
Columbia University |
2001-02 | PHASE3 |
| NCT00607074 | COMPLETED | Giardiasis |
University of Cambridge |
2003-06 | |
| NCT00222547 | COMPLETED | Village Children |
University of Oxford |
1999-01 | PHASE4 |
| NCT00002191 | COMPLETED | Protozoan Infections; HIV Infections |
SmithKline Beecham |
PHASE3 | |
| NCT00004403 | COMPLETED | Epilepsy; Cysticercosis |
Johns Hopkins University |
2000-05 | |
| NCT00207753 | COMPLETED | Ascariasis; Trichuriasis; Hookworm Infection; Strongyloidiasis; Pediculosis |
Centers for Disease Control and Prevention |
2005-02 | |
| NCT00344669 | COMPLETED | Low Weight for Age in Preschool Children |
Makerere University |
2000-08 | |
| NCT00396500 | COMPLETED | Malnutrition; Worm Infestation; Under-Fives |
King George's Medical University |
1994-04 | PHASE3 |
| NCT00133458 | WITHDRAWN | Subarachnoid Cysticercosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE3 | |
| NCT00130910 | COMPLETED | HIV Infections; Helminthiasis |
University of Washington |
2006-03 | |
| NCT00215280 | COMPLETED | Mansonelliasis; Pruritus; Lymphoedema; Abdominal Pains |
DBL -Institute for Health Research and Development |
2005-11 |
(data from https://clinicaltrials.gov, updated on 2026-05-01)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).